MedTech Color aims to advance the representation of persons of color in the medical device industry. Here's how...
Being a catalyst for professional development
Granting access to a diversified Medtech Professional network
To build a community of African Americans that sponsor & mentor to increase the number of leaders of color in the Medtech industry
To increase the number of African Americans who enter & stay in Medtech
To add tangible value to the Medtech Ecosystem via thought-leadership
Dr. Angelique Johnson
Founder & CEO - MEMStim LLC
Dr. Angelique Johnson is CEO/founder of MEMStim LLC, a company that produces implantable electronics to treat neurological disorders. With a doctorate in Electrical Engineering from the University of Michigan, her work on microfabricated electrode arrays has resulted in several national and international patents, funding from the NSF and NIH, and a feature on the cover of Hearing Research. As an expert in Lean Startup Methodology, Dr. Johnson has educated several founders on how to build successful companies. She is an authority on innovation and entrepreneurship. Dr. Johnson has delivered a congressional briefing on Capitol Hill, served as a speaker for the eighth district of the Federal Reserve, and delivered several international talks. She has been featured on NBC Universal, National Public Radio, The Root news site, Louisville Insider, Business First, and other media outlets. Passionate about people as well as entrepreneurship, Dr. Johnson has led numerous outreach programs to promote tech careers to underrepresented minorities and women. One such progra involved her traveling to Abu Dhabi to increase opportunities in STEM for Middle Eastern and North African Women. Dr. Johnson is CEO/Founder of Vissionaireum, an organization that promotes, trains and equips underrepresented entrepreneurs.
How to Advance Diverse Inclusion in Clinical Studies: Driving Actionable Solutions
This expert panel discussion will highlight actionable practices and policies to drive diverse participant representation (sex/gender, race/ethnicity, and age) in clinical studies, reflective of the population impacted by the disease or condition. Additionally, panelists will discuss retention and recruitment practices, patient engagement strategies that focus on increasing access and participation of minorities and women in clinical studies, and its’ applicability to real-world evidence (RWE), which is increasingly being used in regulatory decisions. The panel will touch upon the different platforms that collect clinical data and which need to identify patient specific aspects and do so accurately as well as ensure that all patients are participating in registry efforts.How to Advance Diverse Inclusion in Clinical Studies: Driving Actionable Solutions